KRISTINA TEN HAAF: Open Payments
NPI 1497465520 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,508 in 58 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $191 · 2025 $1,508
Food & beverage: $1,508
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $286 |
| UCB, Inc. | 4 | $278 |
| GENZYME CORPORATION | 13 | $223 |
| Arcutis Biotherapeutics, Inc. | 11 | $158 |
| LEO Pharma Inc. | 1 | $141 |
| Journey Medical Corporation | 1 | $115 |
| Mallinckrodt Hospital Products Inc. | 3 | $55 |
| Amgen Inc. | 2 | $46 |
| ConvaTec Inc. | 1 | $43 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $38 |
Products named: Bimzelx, DUPIXENT, RINVOQ, Zoryve, ADBRY, SKYRIZI, ACTHAR, OTEZLA.
Industry payments across TX — which companies pay providers there.
